These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26823775)

  • 1. Effect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model.
    He J; Lian C; Fang Y; Wu J; Weng J; Ye X; Zhou H
    Int J Clin Exp Pathol; 2015; 8(11):14542-8. PubMed ID: 26823775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes.
    Uno S; Imagawa A; Saisho K; Okita K; Iwahashi H; Hanafusa T; Shimomura I
    Endocr J; 2010; 57(11):991-6. PubMed ID: 20966598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the pharmacokinetic/pharmacodynamic relationship of a small molecule CXCR3 antagonist, NBI-74330, using a murine CXCR3 internalization assay.
    Jopling LA; Watt GF; Fisher S; Birch H; Coggon S; Christie MI
    Br J Pharmacol; 2007 Dec; 152(8):1260-71. PubMed ID: 17982480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Zychowska M; Mika J
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3418-3437. PubMed ID: 30076959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.
    Christen S; Holdener M; Beerli C; Thoma G; Bayer M; Pfeilschifter JM; Hintermann E; Zerwes HG; Christen U
    Clin Exp Immunol; 2011 Sep; 165(3):318-28. PubMed ID: 21649647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Role of the CXCL10/C-X-C Chemokine Receptor 3 Axis in Promoting Leukocyte Recruitment and Neuronal Injury during Traumatic Optic Neuropathy Induced by Optic Nerve Crush.
    Ha Y; Liu H; Zhu S; Yi P; Liu W; Nathanson J; Kayed R; Loucas B; Sun J; Frishman LJ; Motamedi M; Zhang W
    Am J Pathol; 2017 Feb; 187(2):352-365. PubMed ID: 27960090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.
    Baker MS; Chen X; Rotramel AR; Nelson JJ; Lu B; Gerard C; Kanwar Y; Kaufman DB
    Surgery; 2003 Aug; 134(2):126-33. PubMed ID: 12947308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.
    Ahmadi Z; Arababadi MK; Hassanshahi G
    Inflammation; 2013 Apr; 36(2):364-71. PubMed ID: 23065240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-16-5p inhibits the apoptosis of high glucose-induced pancreatic β cells via targeting of CXCL10: potential biomarkers in type 1 diabetes mellitus.
    Gao X; Zhao S
    Endokrynol Pol; 2020; 71(5):404-410. PubMed ID: 32797474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
    Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A
    J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional redundancy of CXCR3/CXCL10 signaling in the recruitment of diabetogenic cytotoxic T lymphocytes to pancreatic islets in a virally induced autoimmune diabetes model.
    Coppieters KT; Amirian N; Pagni PP; Baca Jones C; Wiberg A; Lasch S; Hintermann E; Christen U; von Herrath MG
    Diabetes; 2013 Jul; 62(7):2492-9. PubMed ID: 23434930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-free impedance responses of endogenous and synthetic chemokine receptor CXCR3 agonists correlate with Gi-protein pathway activation.
    Watts AO; Scholten DJ; Heitman LH; Vischer HF; Leurs R
    Biochem Biophys Res Commun; 2012 Mar; 419(2):412-8. PubMed ID: 22349504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice.
    van Wanrooij EJ; de Jager SC; van Es T; de Vos P; Birch HL; Owen DA; Watson RJ; Biessen EA; Chapman GA; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):251-7. PubMed ID: 18048768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expression of CXCL10/CXCR3 and Effect of the Axis on the Function of T Lymphocyte Involved in Oral Lichen Planus.
    Fang J; Wang C; Shen C; Shan J; Wang X; Liu L; Fan Y
    Inflammation; 2019 Jun; 42(3):799-810. PubMed ID: 30467622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of overlapping but differential binding sites for the high-affinity CXCR3 antagonists NBI-74330 and VUF11211.
    Scholten DJ; Roumen L; Wijtmans M; Verkade-Vreeker MC; Custers H; Lai M; de Hooge D; Canals M; de Esch IJ; Smit MJ; de Graaf C; Leurs R
    Mol Pharmacol; 2014 Jan; 85(1):116-26. PubMed ID: 24174496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological assessment of pancreatic islet hormone content following aerobic exercise training in rats with poorly controlled Type 1 diabetes mellitus.
    McDonald MW; Murray MR; Hall KE; Noble EG; Melling CW
    Islets; 2014; 6(2):e29221. PubMed ID: 25483959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis.
    Qu L; Fu K; Yang J; Shimada SG; LaMotte RH
    Pain; 2015 Sep; 156(9):1737-1746. PubMed ID: 25932692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of CXCL10 in the induction of cell injury and mitochondrial dysfunction.
    Singh L; Arora SK; Bakshi DK; Majumdar S; Wig JD
    Int J Exp Pathol; 2010 Jun; 91(3):210-23. PubMed ID: 20041963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.
    Tanaka S; Nishida Y; Aida K; Maruyama T; Shimada A; Suzuki M; Shimura H; Takizawa S; Takahashi M; Akiyama D; Arai-Yamashita S; Furuya F; Kawaguchi A; Kaneshige M; Katoh R; Endo T; Kobayashi T
    Diabetes; 2009 Oct; 58(10):2285-91. PubMed ID: 19641142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.